TY - JOUR
T1 - Practice testing of generic quality indicators for responsible antibiotic use in nine hospitals in the Dutch–Belgian border area
AU - Monnier, Annelie A
AU - D'Onofrio, Valentino
AU - Willemsen, Ina
AU - Kluytmans-van den Bergh, Marjolein F Q
AU - Kluytmans, Jan A J W
AU - Schuermans, Annette
AU - Leroux-Roels, Isabel
AU - Gyssens, Inge C
N1 - Funding Information:
The i-4-1-Health project was financed by the Interreg V Flanders – The Netherlands programme, the cross-border cooperation programme with financial support from the European Regional Development Fund ( ERDF ) (0215). Additional financial support was received from the Dutch Ministry of Health, Welfare and Sport (325911), the Dutch Ministry of Economic Affairs (DGNR-RRE/14191181), the Province of Noord-Brabant (PROJ-00715/PROJ-01018/PROJ-00758), the Belgian Department of Agriculture and Fisheries (no reference), the Province of Antwerp (1564470690117/1564470-610014) and the Province of East- Flanders (E01/subsidie/VLNL/i-4-1-Health). The authors are free to publish the results from the project without interference from the funding bodies.
Funding Information:
An observational cross-sectional multicentre study was performed to assess the first-time use of the DRIVE-AB IQIs in nine hospitals (three Belgian university hospitals, one Dutch university hospital, three Dutch teaching hospitals and two Dutch general hospitals) in the Dutch–Belgian border area using IRIS and participating in the i-4-1 Health project (Supplementary Table S1) [10,11]. The i-4-1 Health project is a European Union (EU) Interreg funded initiative with the aim of broadening the knowledge regarding antimicrobial resistance and use in different healthcare and veterinary settings in the cross-border region of Belgium and the Netherlands [11]. The IRIS tool measures several patient-, ward-, and care-related variables in a standardized way to assess the quality of infection control and antimicrobial use. The implementation of the IRIS in these nine hospitals is reported elsewhere [11]. Our study focused on the antibiotic therapy section of the IRIS. An overview of the included wards is shown in Supplementary Table S2.The i-4-1-Health project was financed by the Interreg V Flanders – The Netherlands programme, the cross-border cooperation programme with financial support from the European Regional Development Fund (ERDF) (0215). Additional financial support was received from the Dutch Ministry of Health, Welfare and Sport (325911), the Dutch Ministry of Economic Affairs (DGNR-RRE/14191181), the Province of Noord-Brabant (PROJ-00715/PROJ-01018/PROJ-00758), the Belgian Department of Agriculture and Fisheries (no reference), the Province of Antwerp (1564470690117/1564470-610014) and the Province of East-Flanders (E01/subsidie/VLNL/i-4-1-Health). The authors are free to publish the results from the project without interference from the funding bodies.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/11
Y1 - 2022/11
N2 - BACKGROUND: Inpatient quality indicators (IQIs) were previously developed to assess responsible antibiotic use.AIM: Practice testing of these QIs in the hospital setting.METHOD: This study was performed within a Dutch-Belgian border network of hospitals implementing the Infection Risk Scan (IRIS) point prevalence survey (PPS) as part of the i-4-1-Health project. Twenty out of 51 DRIVE-AB IQIs, including 13 structure and seven process IQIs, were tested. Data on structure IQIs were obtained through a web-based questionnaire sent to the hospital medical microbiologists. PPS data from October to December 2018 were used to calculate performance scores for the process QIs.FINDINGS: Nine hospitals participated. Regarding structure IQIs: the lowest performance scores were observed for recommendations for microbiological investigations in the guidelines and the use of an approval system for restricted antibiotics. In addition, most hospitals reported that some antibiotics were out of stock due to shortages. Regarding process IQIs: 697 systemic antibiotic prescriptions were used to calculate performance scores. The lowest score was observed for documentation of an antibiotic plan in the medical file (58.8%). Performance scores for IQIs on guideline compliance varied between 74.1% and 82.3% for different aspects of the antibiotic regimen (duration, choice, route, timing).CONCLUSION: This multicentre practice testing of IQIs identified improvement targets for stewardship efforts for both structure and process aspects of antibiotic care (approval system for restricted antibiotics, documentation of antibiotic plan). These results can guide the design of future PPS studies and a more extensive evaluation of the clinimetric properties of the IQIs.
AB - BACKGROUND: Inpatient quality indicators (IQIs) were previously developed to assess responsible antibiotic use.AIM: Practice testing of these QIs in the hospital setting.METHOD: This study was performed within a Dutch-Belgian border network of hospitals implementing the Infection Risk Scan (IRIS) point prevalence survey (PPS) as part of the i-4-1-Health project. Twenty out of 51 DRIVE-AB IQIs, including 13 structure and seven process IQIs, were tested. Data on structure IQIs were obtained through a web-based questionnaire sent to the hospital medical microbiologists. PPS data from October to December 2018 were used to calculate performance scores for the process QIs.FINDINGS: Nine hospitals participated. Regarding structure IQIs: the lowest performance scores were observed for recommendations for microbiological investigations in the guidelines and the use of an approval system for restricted antibiotics. In addition, most hospitals reported that some antibiotics were out of stock due to shortages. Regarding process IQIs: 697 systemic antibiotic prescriptions were used to calculate performance scores. The lowest score was observed for documentation of an antibiotic plan in the medical file (58.8%). Performance scores for IQIs on guideline compliance varied between 74.1% and 82.3% for different aspects of the antibiotic regimen (duration, choice, route, timing).CONCLUSION: This multicentre practice testing of IQIs identified improvement targets for stewardship efforts for both structure and process aspects of antibiotic care (approval system for restricted antibiotics, documentation of antibiotic plan). These results can guide the design of future PPS studies and a more extensive evaluation of the clinimetric properties of the IQIs.
KW - Antibiotic shortages
KW - Antibiotic use
KW - Antimicrobial stewardship
KW - Point-prevalence survey
KW - Quality indicator
UR - http://www.scopus.com/inward/record.url?scp=85138778316&partnerID=8YFLogxK
U2 - 10.1016/j.jhin.2022.07.030
DO - 10.1016/j.jhin.2022.07.030
M3 - Article
C2 - 35998836
SN - 0195-6701
VL - 129
SP - 153
EP - 161
JO - The journal of Hospital Infection
JF - The journal of Hospital Infection
ER -